phrykt

Retension Pharmaceuticals, Inc. (RTSN): who owns it and who trades it

As of Oct 30, 2026, RTSN insiders reported 2 purchases worth $370K in the last 12 months. The largest buyer was Eric L. Keller (CEO), with $250K.

Latest filing Oct 30, 2026. From Form 4, 13F and Schedule 13D/G filings.

At a glance

Insider trades

In the last 12 months, RTSN insiders reported $370K of open-market purchases and $0 of sales.

Purchases, 12 months
$370K
2 trades, 2 people
Sales, 12 months
$0
0 trades, 0 people
Sales under a 10b5-1 plan
–
Share of sale value
Latest trade
Oct 13, 2026
Filed Oct 13, 2026

Purchases and sales by month

$370K$370KDecFebAprJunAugOct
Purchases Sales Click a bar to show only that month below

Latest trades

DateInsiderRoleTypeSharesPriceValueFiling
Oct 13, 2026Franklin M BergerDirectorPurchase10,000$12.00$120KForm 4
Oct 13, 2026Eric L. KellerCEOPurchase20,800$12.00$250KForm 4

Insiders by value traded

InsiderRoleBoughtSoldLast trade
Eric L. KellerCHIEF EXECUTIVE OFFICER, Director$250K–Oct 13, 2026
Franklin M BergerDirector$120K–Oct 13, 2026
What this data shows, and what it doesn't
  • Shows: open-market purchases and sales by officers, directors and 10%+ owners, reported on Form 4 within two business days of the trade.
  • Leaves out: stock awards, option exercises, shares withheld for tax and gifts. These are not trades at a market price chosen by the insider.
  • "plan" marks a sale made under a Rule 10b5-1 plan, a schedule set up in advance.
  • Fund holders come from 13F reports, a snapshot at quarter end filed up to 45 days later.
  • Filings are self-reported and can be amended. Each trade links to its original filing. Methodology

RTSN short interest

68,609 RTSN shares are sold short.

As of Oct 30, 2026, 68,609 RTSN shares were sold short, up 10.6% from the report before. At the average daily volume of 106,178 shares, buying them all back would take about 1.0 trading days (days to cover).

Every report

Settlement dateShares short% of sharesChangeAvg daily volumeDays to cover
Oct 30, 202668,609–+11%106,1781.0
Oct 15, 202662,034––118,1611.0

Short sellers borrow shares and sell them, hoping to buy them back for less. A high number means many such bets are open. It does not say where the price will go. Source: FINRA equity short interest, reported by brokers twice a month (positions on the 15th and the last business day) and published about 7 business days later. % of shares uses the share count on the company's latest SEC filing. What short interest means · Most shorted stocks

Retension Pharmaceuticals company events

Retension Pharmaceuticals filed 2 reports on Form 8-K in the last 12 months, 1 of them about an important change (leadership). The latest was on Oct 23, 2026.

  1. Oct 23, 2026LeadershipThe Board of Directors of Retension Pharmaceuticals, Inc. appointed Robert Wong as Vice President, Chief Accounting Officer (Principal Accounting Officer) of the Company, effective as of November 2, 2026. Filing
  2. Oct 13, 2026RulesChanged its bylaws or articles. Filing

From 8-K reports, which a company must file within 4 business days of an important event. Where a report is about a change such as a new CEO, the sentence is the first one from the report itself, shortened. Each row links to the original filing. Company events this week

5%+ stakes filed in the last 120 days

Anyone who owns more than 5% of a company must report it on Schedule 13D or 13G. 8 filings named RTSN in the last 120 days.

FiledHolderFormStake
Oct 16, 2026The B Group, Inc.13G10.0%
Oct 16, 2026PVG ASSET MANAGEMENT CORP13G8.3%
Oct 16, 2026PVG ASSET MANAGEMENT CORP13G8.3%
Oct 16, 2026The B Group, Inc.13G10.0%
Oct 15, 2026Laurence W. Lytton13G7.4%
Oct 15, 2026Laurence W. Lytton13G7.4%
Oct 14, 2026Eric Keller13D7.1%
Oct 14, 2026Eric Keller13D7.1%

Questions about Retension Pharmaceuticals, Inc. (RTSN) stock

Are RTSN insiders buying or selling?

In the last 12 months, RTSN insiders reported 2 open-market purchases worth $370K and no sales. The latest trade was on Oct 13, 2026. See every trade.

What is the short interest in RTSN?

As of Oct 30, 2026, 68,609 RTSN shares were sold short, up 10.6% from the report before. At the average daily volume of 106,178 shares, buying them all back would take about 1.0 trading days (days to cover). See the history.

Source: SEC Form 4 (insiders, filed within 2 business days), 13F (funds, up to 45 days after quarter end) and Schedule 13D/13G filings. Only open-market purchases (code P) and sales (code S) are shown. Data only, not investment advice. How we collect it.